Healthcare Sector

LLY

Market Tracker

$1,065.00
-22.38
(-2.06%)
4:00 pm
Next Earnings: (est.) 08/08/23 12:00 am
  • LLY (Selected)

    Eli Lilly and Company
  • LLYVA

  • LLYVK

  • LLYX

LLY Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

LLY Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

LLY Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

LLY Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

LLY Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

LLY Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
01/30/2026 CALL $1,180.00 805 +650 +419.35%
01/23/2026 CALL $1,100.00 2,108 +513 +32.16%
01/30/2026 PUT $1,015.00 956 +465 +94.70%
01/23/2026 CALL $1,110.00 1,259 +405 +47.42%
01/23/2026 CALL $1,090.00 809 +341 +72.86%
02/20/2026 PUT $920.00 781 +339 +76.70%
01/23/2026 CALL $1,070.00 576 -61 -9.58%
01/23/2026 PUT $865.00 287 -63 -18.00%
01/23/2026 PUT $1,005.00 225 -66 -22.68%
03/20/2026 CALL $1,200.00 2,418 -89 -3.55%
01/30/2026 PUT $960.00 146 -97 -39.92%
01/23/2026 PUT $1,090.00 204 -227 -52.67%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

LLY Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 2.74% 26M 11.45B
Vanguard 500 Index Fund 1.92% 18.23M 8.03B
Vanguard/Primecap Fund 1.56% 14.85M 6.54B
Fidelity 500 Index Fund 0.91% 8.65M 3.81B
SPDR S&P 500 ETF Trust 0.90% 8.54M 3.76B
Vanguard Specialized-Health Care Fund 0.80% 7.64M 3.37B
iShares Core S&P 500 ETF 0.74% 7.04M 3.1B
Washington Mutual Investors Fund 0.73% 6.95M 3.06B
Growth Fund Of America Inc 0.71% 6.7M 2.95B
Select Sector SPDR Fund-Health Care 0.67% 6.41M 2.82B

LLY News

  • 3 Growth Stocks to Invest $1,000 in Right Now

    01/24 09:15 pm

    The Motley Fool

    Read more
  • Should You Dump Eli Lilly's Shares After This Setback?

    01/24 04:05 pm

    The Motley Fool

    Read more
  • Weight Loss Drugs Market Is Crowded But Structure Therapeutics CEO Has A Strategy For It

    01/23 10:18 am

    Benzinga

    Read more
  • Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026

    01/23 06:10 am

    The Motley Fool

    Read more
  • Postpartum Depression Drugs Market Size to Surpass USD 1.97 Billion by 2033, Due to Increasing Awareness & Fast Development of Pharmaceuticals – SNS Insider

    01/22 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Halper Sadeh LLC Encourages VTYX and SNCY Shareholders to Contact the Firm to Discuss Their Rights

    01/21 03:42 pm

    GlobeNewswire Inc.

    Read more
  • What Happened to Viking Therapeutics in 2025, And Is it a Buy for 2026?

    01/20 04:05 pm

    The Motley Fool

    Read more
  • 3 Biotech Stocks to Keep an Eye on in 2026

    01/20 09:41 am

    Investing.com

    Read more
  • Down 55%, Should You Buy the Dip on Pfizer?

    01/19 04:24 pm

    The Motley Fool

    Read more
  • Prediction: 2026 Will Be the Year of Eli Lilly

    01/19 05:10 am

    The Motley Fool

    Read more
  • Continuous Bioprocessing Market Set to Surpass Valuation of US$ 2,331.98 Million By 2035 | Astute Analytica

    01/16 01:38 pm

    GlobeNewswire Inc.

    Read more
  • FDA Shows Caution, Delays Trump-Backed Fast-Track Drugs Over Risks (UPDATED)

    01/16 09:32 am

    Benzinga

    Read more
  • InSilico Lands Drug Discovery Deal After Hong Kong IPO

    01/15 07:44 am

    Benzinga

    Read more
  • Digbi Health Publishes Peer-Reviewed Data Demonstrating Significant Cost Savings for Employers Via Its Precision Biology Telehealth Platform to Manage GLP-1, Metabolic, and GI Costs

    01/15 04:26 am

    GlobeNewswire Inc.

    Read more
  • Eli Lilly's Most Promising Weight Loss Drug May Come With a Surprising Benefit: Pain Relief

    01/14 03:15 pm

    The Motley Fool

    Read more
  • Why Eli Lilly Stock Gained 39.2% In 2025

    01/14 02:13 pm

    The Motley Fool

    Read more
  • A Fresh IPO That Long-Term Investors Shouldn’t Ignore

    01/14 12:20 pm

    Investing.com

    Read more
  • Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

    01/14 12:15 pm

    The Motley Fool

    Read more
  • Is It Time to Dump Your Shares of Eli Lilly?

    01/14 09:32 am

    The Motley Fool

    Read more
  • Eli Lilly Stock Rallies as Ventyx Deal Calms Wegovy Concerns

    01/14 02:23 am

    Investing.com

    Read more
  • A 10% Owner Of Structure Therapeutics Shed Shares

    01/13 03:33 pm

    The Motley Fool

    Read more
  • Eli Lilly vs Novo Nordisk: Which Company Will Dominate the Weight Loss Drug Market in 2026?

    01/13 11:15 am

    The Motley Fool

    Read more
  • Aktis Oncology Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

    01/13 07:30 am

    Benzinga

    Read more
  • Why Tempus AI Stock Rose Today

    01/12 08:07 pm

    The Motley Fool

    Read more
  • Nvidia Trades Cheap Relative to Its 2030s Earnings Path

    01/12 03:38 pm

    Investing.com

    Read more
  • NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI

    01/12 11:00 am

    GlobeNewswire Inc.

    Read more
  • NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery

    01/12 11:00 am

    GlobeNewswire Inc.

    Read more
  • Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

    01/10 07:12 pm

    GlobeNewswire Inc.

    Read more
  • Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026

    01/09 11:20 pm

    GlobeNewswire Inc.

    Read more
  • Eli Lilly Study Finds Zepbound Dual Treatment Improves Arthritis, Helps Patients Lose Weight

    01/09 09:45 am

    Benzinga

    Read more
  • Alveus Therapeutics annoncerer serie A-financiering på 160 mio. USD til næste generations behandlinger mod fedme og stofskiftesygdomme

    01/09 04:13 am

    GlobeNewswire Inc.

    Read more
  • Aktis Oncology Announces Pricing of its Upsized Initial Public Offering

    01/08 09:48 pm

    GlobeNewswire Inc.

    Read more
  • Pharmacy XD Launches Nationally Licensed Direct-to-Patient Mail Order Pharmacy and Distribution Platform - Headquartered in Florida's Fastest-Growing Healthcare Corridor

    01/08 05:30 pm

    Benzinga

    Read more
  • The Best Technology ETF to Invest $1,000 in Right Now

    01/08 11:22 am

    The Motley Fool

    Read more
  • Stock Market Today: Dow Futures Up, S&P 500 And Nasdaq Slip As ADP Jobs Data Signals Modest Rebound— Mobileye, Penguin Solutions In Focus (UPDATED)

    01/07 10:06 am

    Benzinga

    Read more
  • 2 Dividend ETFs to Buy With $500 and Hold Forever

    01/07 08:30 am

    The Motley Fool

    Read more
  • My Top 5 Stocks to Buy in Early 2026

    01/07 05:15 am

    The Motley Fool

    Read more
  • Warning: This Skyrocketing Stock Has a Hidden Risk

    01/06 09:30 pm

    The Motley Fool

    Read more
  • Arrowhead Obesity Drugs Show Significant Fat Loss In Early Human Trials

    01/06 11:32 am

    Benzinga

    Read more
  • Should You Buy Eli Lilly Before It Reaches $1 Trillion in Market Value?

    01/06 10:10 am

    The Motley Fool

    Read more
  • Sitryx to attend J.P. Morgan Healthcare Conference 2026 showcasing pipeline of novel small molecule candidates targeting major autoimmune indications

    01/06 08:00 am

    GlobeNewswire Inc.

    Read more
  • Motley Fool Money: Stock Market Naughty and Nice List

    01/06 01:33 am

    The Motley Fool

    Read more
  • These 3 Stocks Trade at Discounts the Market Won’t Ignore Forever

    01/05 01:35 pm

    Investing.com

    Read more
  • How Trump Moved Stocks In 2025: Crypto, Drones, Health Care Sectors

    01/04 04:55 pm

    Benzinga

    Read more
  • Pfizer: Why Wall Street Gave Up—And Why That May Be a Mistake

    01/02 12:24 pm

    Investing.com

    Read more
  • FDA Approves Novo Nordisk’s Wegovy Pill: A Game Changer for 2026

    01/01 03:12 am

    Investing.com

    Read more
  • Drugmakers Plan Fresh Price Hikes On 350 Medicines In 2026

    12/31 09:59 am

    Benzinga

    Read more
  • Best Wegovy Alternative for 2026? FDA Approves Oral Semaglutide as Patients Evaluate Compounded Telehealth Access — Direct Meds Examined as Verification Case Study

    12/30 09:57 pm

    GlobeNewswire Inc.

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: